Original Contributions: Links

Interim-analysis of the COSA (COVID-19 patients treated with the Seraph® 100 Microbind® Affinity filter) registry

Julius J Schmidt, Dan Nicolae Borchina, Mariet van´t Klooster, Khalida Bulhan-Soki, Reuben Okioma, Larissa Herbst, Diego Sandoval Rodríguez, Vedran Premužić, Stefan Büttner, Birgit Bader, Wojciech Serednicki, Ewa Zasada, Michael Schmitz, Ralf A Quabach, Maria Hrincheva, Thomas Fühner, Jan T Kielstein

Fosfomycin single- and multiple-dose pharmacokinetics in patients undergoing prolonged intermittent renal replacement therapy

Lisa K V Gerecke, Julius J Schmidt, Carsten Hafer, Gabriele Eden, Stefanie M Bode-Böger, Jens Martens-Lobenhoffer, Tobias Welte, Jan T Kielstein

Original Contributions: Files

Safety and efcacy of the Seraph® 100 Microbind® Afnity Blood Filter to remove bacteria from the blood stream: results of the frst in human study

Gabriele Eden, Julius J. Schmidt, Stefan Büttner, Philipp Kümpers, Carsten Hafer, Alexandros Rovas, Benjamin Florian Koch, Bernhard M. W. Schmidt and Jan T. Kielstein

2 MB | 18.06.2022 11:30

Evaluation of the ideal length of the Seldinger needle for internal jugular vein catheter placement

Clara M. Wenzel, Torsten M. Meyer, Dietrich Stoevesandt, Heike Kielstein & Jan T. Kielstein

1 MB | 18.02.2022 15:29

In vitro elimination of anti-infective drugs by the Seraph 100 Microbind affinity blood filter

Julius J. Schmidt, Gabriele Eden, Malin-Theres Seffer, Manuela Winkler and Jan T. Kielstein

425 KB | 21.05.2020 19:43

Single- and multiple-dose pharmacokinetics and total removal of colistin in critically ill patients with acute kidney injury undergoing prolonged intermittent renal replacement therapy

Julius J. Schmidt, Ann-Kathrin Strunk, Sascha David, Stefanie M. Bode-Boger, Jens Martens-Lobenhoffer, Wolfgang Knitsch, Stephan Scherneck, Tobias Welte and Jan T. Kielstein

322 KB | 11.01.2019 11:22

Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers

Hannah Knaup, Klaus Stahl, Bernhard M. W. Schmidt, Temitayo O. Idowu, Markus Busch, Olaf Wiesner, Tobias Welte, Hermann Haller, Jan T. Kielstein, Marius M. Hoeper and Sascha David

1 MB | 06.11.2018 07:52

Improved short- and long-term outcome of allogeneic stem cell recipients admitted to the intensive care unit: a retrospective longitudinal analysis of 942 patients

Catherina Lueck, Michael Stadler, Christian Koenecke, Marius M. Hoeper, Elke Dammann, Andrea Schneider, Jan T. Kielstein, et al.

1 MB | 03.09.2018 18:22

Therapeutic plasma exchange in a tertiary care center: 185 patients undergoing 912 treatments - a one-year retrospective analysis

Julius J. Schmidt, Firas Asper, Gunilla Einecke, Gabriele Eden, Carsten Hafer and Jan T. Kielstein

763 KB | 03.09.2018 18:15

Hypoxia-induced long non-coding RNA Malat1 is dispensable for renal ischemia/reperfusion-injury

Malte Kölling, Celina Genschel, Tamas Kaucsar, Anika Hübner, Song Rong, Roland Schmitt, Inga Sörensen-Zender, George Haddad, Andreas Kistler, Harald Seeger, Jan T. Kielstein, Danilo Fliser, Hermann Haller, Rudolf Wüthrich, Martin Zörnig, Thomas Thum & Johan Lorenzen

3 MB | 03.09.2018 18:15

Higher levels of SDMA and not ADMA are associated with poorer survival of trial patients with systemic ANCA-associated vasculitis

Uta Erdbrügger , Jan T. Kielstein , Kerstin Westman , Jennie Z. Ma , Wenjun Xin , Stephanie M. Bode-Böger , Mȧrten Segelmark , Niels Rasmussen , Kirsten de Groot

160 KB | 03.09.2018 18:15

Preoperative serum uric acid predicts incident acute kidney injury following cardiac surgery

T. Kaufeld, K. A. Foerster, T. Schilling, J. T. Kielstein, J. Kaufeld, M. Shrestha, H. G. Haller, A. Haverich and B. M. W. Schmidt

547 KB | 03.09.2018 18:15